Evidence map›Paper›PMID 39592153›Full record

ArticleBriefings in bioinformatics2024

miCGR: interpretable deep neural network for predicting both site-level and gene-level functional targets of microRNA.

Xiaolong Wu, Lehan Zhang, Xiaochu Tong, Yitian Wang, Zimei Zhang, Xiangtai Kong, Shengkun Ni, Xiaomin Luo, Mingyue Zheng, Yun Tang and 1 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaolong WuSchool of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.
Lehan ZhangDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Xiaochu TongDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Yitian WangDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Zimei ZhangDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Xiangtai KongDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Shengkun NiDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Xiaomin LuoDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Mingyue ZhengDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.ORCID 0000-0002-3323-3092
Yun TangSchool of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.ORCID 0000-0003-2340-1109
Xutong LiDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.ORCID 0000-0001-9547-0643

Funding

Chinese Academy of sciences XDB0850000National Key Research and Development Program of China 2023YFC2305904National Natural Science Foundation of China 82273855Shanghai Institute of Materia Medica Chinese Academy of Sciences SIMM0220232001
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are critical regulators in various biological processes to cleave or repress translation of messenger RNAs (mRNAs). Accurately predicting miRNA targets is essential for developing miRNA-based therapies for diseases such as cancer and cardiovascular disease. Traditional miRNA target prediction methods often struggle due to incomplete knowledge of miRNA-target interactions and lack interpretability. To address these limitations, we propose miCGR, an end-to-end deep learning framework for predicting functional miRNA targets. MiCGR employs 2D convolutional neural networks alongside an enhanced Chaos Game Representation (CGR) of both miRNA sequences and their candidate target site (CTS) on mRNA. This advanced CGR transforms genetic sequences into informative 2D graphical representations based on sequence composition and subsequence frequencies, and explicitly incorporates important prior knowledge of seed regions and subsequence positions. Unlike one-dimensional methods based solely on sequence characters, this approach identifies functional motifs within sequences, even if they are distant in the original sequences. Our model outperforms existing methods in predicting functional targets at both the site and gene levels. To enhance interpretability, we incorporate Shapley value analysis for each subsequence within both miRNA sequences and their target sites, allowing miCGR to achieve improved accuracy, particularly with more lenient CTS selection criteria. Finally, two case studies demonstrate the practical applicability of miCGR, highlighting its potential to provide insights for optimizing artificial miRNA analogs that surpass endogenous counterparts.

Indexed as

Computational BiologyDeep LearningMicroRNAsNeural Networks, ComputerAlgorithmsHumansRNA, MessengerMicroRNAsRNA, Messengerchaos game representationconvolutional neural networkdeep learningMicroRNAtarget prediction

Identifiers

PMID39592153
PMCPMC11596087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.